Drugs & Medicine Recalls

Pharmaceutical recall notices, chemical impurities, and biological contamination.

Showing 24 of 400 results
Pharmaceutical
FDA DrugsClass II

BD PurPrep, Povidone-iodine 8.3% w/w (0.83% available iodine) with isopropyl alc...

Lack of assurance of Sterility: potential product contamination

May 13, 2026CareFusion 213, LLC
Pharmaceutical
FDA DrugsClass II

DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange ...

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

May 13, 2026Fresenius Medical Care Holdings, Inc.
Pharmaceutical
FDA DrugsClass II

Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr. b...

CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit

May 13, 2026Breckenridge Pharmaceutical, Inc.
Pharmaceutical
FDA DrugsClass III

busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufactu...

Subpotent drug

May 13, 2026Unichem Pharmaceuticals USA Inc.
Pharmaceutical
FDA DrugsClass II

DELFLEX, Dextrose Peritoneal Dialysis Solution with attached stay-safe Exchange ...

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

May 13, 2026Fresenius Medical Care Holdings, Inc.
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate Injectable Solution, Narcotic, CII, 1250 mcg/25mL (50 mcg per m...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate injectable Solution in 0.9% Sodium Chloride, Narcotic, (2500 mc...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

Alendronate Sodium Oral Solution, 70 mg/75 mL, 75 mL, Rx only, 4 x 75 mL Single ...

This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.

May 6, 2026Hikma Pharmaceuticals USA INC
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 50 mcg/5mL)(10 mcg...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate Injectable Solution, NARCOTIC, Cii, 1000 mcg/100 mL (10 mcg per...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 mL), Made in...

Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

May 6, 2026Thea Pharma, Inc.
Pharmaceutical
FDA DrugsClass II

Similasan, iVIZIA, Sterile Lubricant Eye Drops (Povidone 0.5%), 0.33 Fl oz (10 m...

Lack of Assurance of Sterility: This recall has been initiated due to CGMP deviations found by the FDA during an inspection of the manufacturer.

May 6, 2026Thea Pharma, Inc.
Pharmaceutical
FDA DrugsClass II

GenTeal Tears, Lubricant Eye Gel, Sterile, 10g (0.34 Fl oz), Distributed by: Alc...

Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.

May 6, 2026Alcon Research LLC
Pharmaceutical
FDA DrugsClass II

Phenylephrine Hydrochloride Injectable Solution, 40mg, 250*mL Bag, wells pharma ...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

fentaNYL Citrate Injectable Solution in 0.9% Sodium Chloride, 1000 mcg/50mL (20 ...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass II

Systane, Lubricant Eye Gel, Night Gel, Sterile, 10g (0.35 oz), Processed in Fran...

Lack of Assurance of Sterility: Due to FDA inspection observations that it believes may impact product quality.

May 6, 2026Alcon Research LLC
Pharmaceutical
FDA DrugsClass II

Ketamine Hydrochloride Injectable Solution, 50mg/ml, (50 mg per mL) Volume: 1 mL...

cGMP deviations.

May 6, 2026Wells Pharma of Houston LLC
Pharmaceutical
FDA DrugsClass III

Levocarnitine Injection, USP, 1 g/5 mL (200 mg/mL), 5 mL Single-Dose Vial, For i...

Labeling: Missing Label

May 6, 2026American Regent, Inc.
Pharmaceutical
FDA DrugsClass III

Lidocaine Wound Gel (Benzalkonium Chloride, 0.13% and Lidocaine Hydrochloride, 2...

Failed PH Specifications

May 6, 2026Water-Jel Technologies, LLC
Pharmaceutical
FDA DrugsClass II

Optase Dry Eye Intense Drops (Glycerin 0.2%), packaged in 0.33 fl oz, Sterile, M...

Lack of Assurance of Sterility

May 6, 2026SCOPE HEALTH
Pharmaceutical
FDA DrugsClass II

Omega-3-Acid, Ethyl Esters, Capsules, USP, 1 gram, 50 capsules (5 x 10 unit dose...

Failed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.

Apr 29, 2026The Harvard Drug Group LLC
Pharmaceutical
FDA DrugsClass II

DEXTROSE INJECTION USP, 70%, 2000 mL bags, Rx only, Sterile, B. Braun Medical In...

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Apr 29, 2026B BRAUN MEDICAL INC
Pharmaceutical
FDA DrugsClass II

LACTATED RINGER'S IRRIGATION, 3000 mL bags, Sterile, Ex only, B. Braun Medical I...

Lack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.

Apr 29, 2026B BRAUN MEDICAL INC
Pharmaceutical
FDA DrugsClass II

FRESHKOTE LUBRICANT EYEDROPS, Sterile, 0.33 FL OZ (10mL), Harrow Eye LLC, Nashvi...

Lack of Assurance of Sterility

Apr 29, 2026Harrow Eye LLC